Article
Bioinformatics analysis of KIF20A, a potential therapeutic target for glioblastoma
2021-01-05
Abstract excerpt
<h4>Background: </h4> Glioblastoma (GBM) is a malignant brain tumor with high mobility. The median survival time of GBM patients is 15 months. Currently, there is no effective treatment for improving the prognosis of the GBM due to a lack of prognostic markers. Materials and methods: To predict core therapeutic targets for GBM, we analyzed four microarray datasets (GSE49810, GSE50161, GSE65624, and GSE90604) selec...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fe1b435c-df86-55ce-a8e2-b8581282ae36
- DOI
- 10.21203/rs.3.rs-138484/v1
